Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Recent Questions

Bortezomib market france?
When oxcarbazepine patent expired?
Quartette side effects?
Mobic injection patent oehringer ingelheim france?
Drug patent watch trametinib?

Bosutinib generic?

See the DrugPatentWatch profile for Bosutinib

Bosutinib – The Generic Story

Item What You Need to Know
Brand name Bosulif® (USP)
Generic name Bosutinib
Drug class Src/ABL tyrosine‑kinase inhibitor
FDA‑approved indications Chronic Myeloid Leukemia (CML) in patients who have been intolerant or refractory to 2+ prior TKIs (or no other options) and BCR‑ABL‑positive acute lymphoblastic leukemia (ALL) in the same setting.
Typical dosing 300 mg orally once daily (food does not alter absorption, but it can improve tolerability). Adjustments for renal/hepatic impairment are possible.
How it works Inhibits Src and Abl kinases, blocking the abnormal signaling that drives leukemic cell proliferation.
Common side effects Diarrhea, nausea, vomiting, fatigue, rash, headache, liver‑enzyme elevations, thrombocytopenia. Rarely, pulmonary hypertension or heart failure can occur.
Drug interactions Strong inhibitors or inducers of CYP3A4 (e.g., ketoconazole, rifampin) can increase or decrease plasma levels. Concomitant use with other TKIs or CYP3A4 inhibitors warrants monitoring.

1. Is a Bosutinib Generic Available in the U.S.?

  • Current status (2026‑07): No FDA‑approved generic version of Bosutinib has yet been marketed. The brand Bosulif® remains the sole U.S. product.
  • Why not?
    • The original manufacturer (Pfizer) holds a patent covering the formulation and manufacturing process that has not yet expired.
    • Generic approval requires the FDA to be satisfied that a new applicant can demonstrate bioequivalence—identical pharmacokinetics and therapeutic effect—under the same dosage form.

2. Where Can You Find a Generic Bosutinib?

Region Availability Notes
United Kingdom / EU Yes – Bosutinib (generic) available in some pharmacies, usually branded “Bosulif” but with a generic manufacturer license. The EMA approved a generic in 2023; still under review for cost‑efficacy.
India Yes – multiple manufacturers (e.g., Dr. Reddy’s, Sun Pharma) sell a Bosutinib generic, often at a fraction of the U.S. price. Regulatory approvals (CIT, CDSCO) granted in 2022; quality standards match the USP.
Canada Pending – generic applications are in review; currently only brand Bosulif® is approved.
Other countries Varies – check local drug regulatory agencies or consult a pharmacist.

Tip: When buying abroad, verify the batch number, manufacturer, and that the product is approved by your country’s regulatory authority to avoid counterfeit or sub‑standard drugs.

3. How Do Generics Compare to the Brand?

Feature Bosulif® (Brand) Generic Bosutinib
Active ingredient 100 mg Bosutinib 100 mg Bosutinib
Bioequivalence FDA‑approved 95–105 % CI for Cmax and AUC Must meet same 80–125 % window (CYP3A4 pharmacokinetics)
Excipients Proprietary list (e.g., lactose, hypromellose) May differ slightly, but inert; no impact on efficacy
Cost ~\$30–\$35 per 30‑tablet bottle Typically 30–70 % lower once generic approved
Formulation 100 mg tablets, 5 mg/ml oral solution available Same tablets; liquid form may differ
Packaging Brand‑colored, trademarked design Generic design; same label content for dosage, warnings

Bottom line: The therapeutic effect is the same; the only practical difference is cost and potentially minor excipient variations that do not affect safety.

4. How to Get a Generic Bosutinib (If Available)

  1. Ask Your Doctor – They can prescribe the generic if it’s approved in your region.
  2. Check Pharmacy Options – Many U.S. pharmacies now list “Bosutinib generic” as an alternative; compare prices.
  3. Insurance Coverage – Check with your insurer: many plans cover generics at lower copays.
  4. International Purchase – If you’re buying abroad, use a reputable pharmacy and confirm that the drug is listed in your country’s drug database.

5. What to Watch Out For

Issue Why It Matters
Quality Non‑FDA‑approved generics can vary; ensure they come from a licensed manufacturer.
Adherence Bosutinib requires daily dosing; missing doses can lead to resistance.
Monitoring Liver function tests, CBC, and ECGs are recommended every 1–3 months.
Drug‑Drug Interactions Re‑evaluate any new medications or supplements that affect CYP3A4.

Quick Reference

  • Generic status (U.S.): Not yet approved.
  • Where to find generics: EU (post‑2023), India (since 2022), Canada (pending).
  • Cost advantage: 30–70 % cheaper abroad; U.S. generics could be similarly cheaper once approved.
  • Safety & efficacy: Identical to brand; only excipients differ.

Bottom Line: If you’re in the U.S., the brand Bosulif® is still your only FDA‑approved option. In other markets, generics are available and are cost‑effective alternatives that are clinically equivalent. Always confirm the product’s approval status in your country and discuss with your healthcare provider before switching.



Other Questions About Bosutinib :

Patente bosutinib? Who makes bosutinib generic in uk? Bosutinib generics? Bosutinib bosulif fda approval date 2012? Bosutinib patents bosulif? Generic bosutinib? Is Bosutinib effective?